PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30347750-5	2018	Based on our previous experience, by using gadolinium-enriched paramagnetic fluorescence micellar nanoparticles conjugated with AP9 (NAP9), an EMMPRIN-specific binding peptide, magnetic resonance sequences allowed non-invasive visualization of carotid EMMPRIN in NOS3/apoE over apoE control mice, in which atheroma plaques were significantly reduced.	Gadolinium	43-53	apolipoprotein E	Mus musculus	268-272	
30347750-5	2018	Based on our previous experience, by using gadolinium-enriched paramagnetic fluorescence micellar nanoparticles conjugated with AP9 (NAP9), an EMMPRIN-specific binding peptide, magnetic resonance sequences allowed non-invasive visualization of carotid EMMPRIN in NOS3/apoE over apoE control mice, in which atheroma plaques were significantly reduced.	Gadolinium	43-53	apolipoprotein E	Mus musculus	278-282	
26569115-0	2015	Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.	Gadolinium	124-134	apolipoprotein E	Mus musculus	60-76	
17940339-0	2008	In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.	Gadolinium	101-111	apolipoprotein E	Mus musculus	131-147	
25499394-8	2014	Higher gadolinium-based elastin-binding contrast agent uptake was also detected in the aortic arch of ApoE(-/-) compared to WT mice using R(1) maps (R(1) = 1.47 +- 0.06 s(-1) vs. 0.92 +- 0.05 s(-1); P <0.001).	Gadolinium	7-17	apolipoprotein E	Mus musculus	102-106	
23109394-2	2013	In this study the intrinsic ability of two differently sized gadolinium-based contrast agents to enhance atherosclerotic plaques in ApoE(-/-) mice was evaluated with MRI.	Gadolinium	61-71	apolipoprotein E	Mus musculus	132-136	
17089381-0	2006	Gadolinium mixed-micelles: effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis.	Gadolinium	0-10	apolipoprotein E	Mus musculus	88-104	
17089381-7	2006	Significant wall enhancement of ApoE(-/-) mice was observed following administration of 0.015 and 0.038 mmol Gd/kg of both micelle formulations.	Gadolinium	109-111	apolipoprotein E	Mus musculus	32-36